Literature DB >> 29546253

An Exponential Tilt Mixture Model for Time-to-Event Data to Evaluate Treatment Effect Heterogeneity in Randomized Clinical Trials.

Chi Wang1,2, Zhiqiang Tan3, Thomas A Louis4.   

Abstract

Evaluating the effect of a treatment on a time-to-event outcome is the focus of many randomized clinical trials. It is often observed that the treatment effect is heterogeneous, where only a subgroup of the patients may respond to the treatment due to some unknown mechanism such as genetic polymorphism. In this paper, we propose a semiparametric exponential tilt mixture model to estimate the proportion of patients who respond to the treatment and to assess the treatment effect. Our model is a natural extension of parametric mixture models to a semiparametric setting with a time-to-event outcome. We propose a nonparametric maximum likelihood estimation approach for inference and establish related asymptotic properties. Our method is illustrated by a randomized clinical trial on biodegradable polymer-delivered chemotherapy for malignant gliomas patients.

Entities:  

Keywords:  Exponential tilt model; Mixture model; Randomized clinical trial; Time-to-event data; Treatment heterogeneity

Year:  2014        PMID: 29546253      PMCID: PMC5849265          DOI: 10.15406/bbij.2014.01.00006

Source DB:  PubMed          Journal:  Biom Biostat Int J


  6 in total

1.  Mixtures of proportional hazards regression models.

Authors:  O Rosen; M Tanner
Journal:  Stat Med       Date:  1999-05-15       Impact factor: 2.373

2.  Hypothesis testing under mixture models: application to genetic linkage analysis.

Authors:  K Y Liang; P J Rathouz
Journal:  Biometrics       Date:  1999-03       Impact factor: 2.571

3.  On the role of finite mixture models in survival analysis.

Authors:  G J McLachlan; D C McGiffin
Journal:  Stat Methods Med Res       Date:  1994       Impact factor: 3.021

4.  Tests for genetic linkage and homogeneity.

Authors:  M Lemdani; O Pons
Journal:  Biometrics       Date:  1995-09       Impact factor: 2.571

5.  Inference of Tamoxifen's Effects on Prevention of Breast Cancer from a Randomized Controlled Trial.

Authors:  Yu Shen; Jing Qin; Joseph P Costantino
Journal:  J Am Stat Assoc       Date:  2007-12-01       Impact factor: 5.033

6.  Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group.

Authors:  H Brem; S Piantadosi; P C Burger; M Walker; R Selker; N A Vick; K Black; M Sisti; S Brem; G Mohr
Journal:  Lancet       Date:  1995-04-22       Impact factor: 79.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.